StockNews.com started coverage on shares of 22nd Century Group (NASDAQ:XXII – Free Report) in a research note published on Sunday. The brokerage issued a sell rating on the biotechnology company’s stock.
22nd Century Group Price Performance
XXII stock opened at $0.09 on Friday. The company has a debt-to-equity ratio of 1.59, a quick ratio of 0.93 and a current ratio of 1.09. The firm has a 50 day moving average price of $0.13 and a 200-day moving average price of $0.49. 22nd Century Group has a 52-week low of $0.08 and a 52-week high of $4.31. The firm has a market capitalization of $4.25 million, a price-to-earnings ratio of 0.00 and a beta of 1.50.
22nd Century Group (NASDAQ:XXII – Get Free Report) last posted its quarterly earnings data on Tuesday, November 12th. The biotechnology company reported ($0.54) earnings per share for the quarter. 22nd Century Group had a negative net margin of 144.09% and a negative return on equity of 380.39%. The company had revenue of $5.95 million for the quarter.
Institutional Trading of 22nd Century Group
About 22nd Century Group
22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.
See Also
- Five stocks we like better than 22nd Century Group
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Beyond NVIDIA: Top 5 Semiconductor Stocks to Watch for 2025
- Dividend Payout Ratio Calculator
- Netflix Is On Track To Hit $1,000 By Christmas
- Bank Stocks – Best Bank Stocks to Invest In
- UMAC Stock Climbs Amid Trump Jr. Appointment and Meme Stock Hype
Receive News & Ratings for 22nd Century Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 22nd Century Group and related companies with MarketBeat.com's FREE daily email newsletter.